A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback